Latest Capital Raise News

OMG Group has raised $2 million through a share placement to boost inventory and capitalise on growing demand from major Australian retailers and ecommerce channels.

MRG Metals has successfully raised over $500,000 through an entitlement offer, issuing new options to fund exploration in Mozambique while directors fully subscribed and plan further participation.

Basin Energy Limited has secured $1.25 million to advance exploration of uranium and rare earth metals across strategic Tier-1 jurisdictions, positioning itself amid rising global demand for clean energy minerals.

Basin Energy has agreed to acquire NeoDys Limited, gaining a dominant uranium and rare earth portfolio in northwest Queensland, fully funded to commence drilling in late 2025.

BluGlass Limited reported a 16% rise in revenue to $11.7 million for FY25, driven by key US Department of Defense contracts and new partnerships. However, the company’s net loss increased 8% to nearly $11 million amid ongoing R&D investment and operational scaling.

Nimy Resources has successfully raised $1.72 million through an oversubscribed share placement to fast-track copper and gallium exploration at its Mons Project in Western Australia.

Pure Foods Tasmania has secured a $400,000 investment from entrepreneurs Jon Kontopos and Matthew Abrahams as part of a broader $750,000 capital raising effort, reinforcing confidence in the company’s turnaround plan ahead of its upcoming shareholder vote.

Associate Global Partners Limited (AGP) reported an 8.1% increase in funds under management to $1.397 billion in FY25, driven by robust investment performance and a successful capital raising. The firm also narrowed its net loss significantly and strengthened its distribution capabilities, setting a positive tone for FY26.

Dome Gold Mines Ltd invites eligible shareholders to participate in a $5 million Share Purchase Plan at $0.15 per share, aiming to fund the transition to production at its Sigatoka Sands Project and exploration of other Fijian assets.

Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.

Metrics Master Income Trust (MXT) reported a solid FY2025 with $2.44 billion in assets under management following a $315 million capital raise, while delivering an annual net return of 8.17%, outperforming its benchmark.

MA Credit Income Trust (ASX, MA1) has announced a $190.5 million non-renounceable entitlement offer at a 3.4% discount, aiming to bolster its private credit investments across asset-backed, direct asset, and corporate lending sectors.